CYP cynata therapeutics limited

Ann: Quarterly Activity Report & Appendix 4C, page-5

  1. 3 Posts.
    I think that if MSB's therapy is accepted ,then as CYP has a more efficient way to produce stem cells it will benefit because of the need for greater quantities.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
0.005(3.33%)
Mkt cap ! $35.02M
Open High Low Value Volume
15.5¢ 15.5¢ 15.5¢ $2.903K 18.72K

Buyers (Bids)

No. Vol. Price($)
6 230650 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 90337 3
View Market Depth
Last trade - 10.20am 17/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.